flatulence; aerophagia (increased ingestion of air when eating); formation of gases in the postoperative period; preparation for radiography and ultrasound; with various gas accumulations in the gastrointestinal tract.
Espumizan L Composition
active substance: simeticone
1 ml oral drops, emulsion (25 drops) contains simethicone 40 mg
excipients: polyethylene glycol stearate, glycerin monostearate, carbomer, banana flavor *, potassium acesulfame, sorbitol solution that does not crystallize (E 420), sodium chloride, sodium citrate, sodium hydroxide, sorbic acid, purified water.
Contains flavors identical to natural and propylene glycol.
Espumizan L Dosage form
Oral drops, emulsion.
Basic physical and chemical properties. Low-viscosity milky white emulsion.
Means used for functional disorders of the gastrointestinal tract. Means used for functional disorders of the gastrointestinal tract. Silicones. ATX code A03A X13.
Espumisan® L contains simethicone, a stable surfactant polydimethylsiloxane, as an active ingredient. It changes the surface tension of the gas bubbles contained in the food gruel and the mucous membranes of the digestive tract, as a result of which they disintegrate. The released gases can then be absorbed by the intestinal walls, and also excreted due to intestinal peristalsis.
Simethicone has an exclusively physical effect, it does not participate in chemical reactions and is inert in pharmacological and physiological terms.
Simethicone is not absorbed when taken orally and is excreted unchanged through the gastrointestinal tract.
Espumizan L Indications
For the symptomatic treatment of complaints from the gastrointestinal tract associated with gas, for example, with flatulence, with colic in newborns.
As an aid in diagnostic examinations of the abdominal cavity, such as X-ray examinations, ultrasound diagnostics and preparation for gastroduodenoscopy
As an antifoam agent in case of intoxication with surfactants (washing powders or detergents).
Hypersensitivity to the active substance or to any of the excipients, complete intestinal obstruction.
Interaction with other medicinal products and other types of interactions
Unknown for today.
At the first appearance and / or persistent complaints of abnormalities from the abdominal cavity, a clinical examination should be carried out.
This medicinal product contains sorbitol. Patients with rare hereditary fructose intolerance should not use this drug.
Espumisan® L should be used with caution in patients with obstructive diseases of the gastrointestinal tract.